First Major European Sales and Revenue for MGC Derma Range
Filed with ASX · · 3 pages · English
Earlier from Argent Biopharma
- Cleansing Prospectus
- EU Registration Commenced for CBD Derma Product Sales
- September Quarter Activity and Cashflow Report
- Operations Update - Multiple Revenue Streams Imminent
- New Med Cannabis White Paper Developed with Uni of Sydney
Later from Argent Biopharma
- New Panax Acquisition Agreement Signed, Settlement Imminent
- MXC Operations Update
- European CPNP Approval Granted for Derma Products
- Commencement of Dermatological Clinical Trials
- Panax Acquisition Completed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma